(Date:12/4/2009)..., Dec. 4 The following ...hysicians and Surgeons (AAPS): , ,DATE: ...,PLACE: Grand Hyatt Hotel Washington ... Renwick Room (lower level 2),EVENT: ...e, opposition to U.S. Senate he...
(Date:12/4/2009)...N and HOUSTON, Dec. 4 AE...(Nasdaq: CYBX ) announced today that Vagus Nerve... implantable medical device for the treatment of r...ations at the American Epilepsy Society,s (AES) A...ynes Convention Center in Boston, Massachusetts. ...
(Date:12/4/2009)... North American Seminars Inc. is now accepting med...al education courses at their medical facility in ...ts operation and capabilities to the medical commu...ate their physical therapy and occupational therap...over 250 live training events. , ...
(Date:12/4/2009)... Best-Selling author and Personal & Organizati...al Transformation through Accountability! , ...er 4, 2009 -- IMPAQ Accountability Business Cons..., best-selling Author, renowned Speaker, and CEO &...ultants Inc., will present at the 14th Internation...
(Date:12/3/2009)..., Dec. 3 The American R...International Brotherhood of Teamsters, Local 929 ...leaving the facility, interfering with blood shipm....newscom.com/cgi-bin/prnh/20081216/DC52619LOGO ) ...nst the American Red Cross Blood Services Penn-Jer...
Breaking Medicine News(10 mins):Health News:State Legislators in D.C. To Blast Senate Healthcare Bill at News Conference; Say Tramples States' Rights, and Saddles with Massive Medicaid Bills; Push Bills to Block Federal Mandates 2Health News:NYU Langone Medical Center Study Shows VNS Therapy is a Safe and Effective Treatment for Refractory Epilepsy 2Health News:NYU Langone Medical Center Study Shows VNS Therapy is a Safe and Effective Treatment for Refractory Epilepsy 3Health News:North American Seminars Inc. Opens Its 2010 Physical Therapy Continuing Medical Education Course Sponsorship Program 2Health News:North American Seminars Inc. Opens Its 2010 Physical Therapy Continuing Medical Education Course Sponsorship Program 3Health News:North American Seminars Inc. Opens Its 2010 Physical Therapy Continuing Medical Education Course Sponsorship Program 4Health News:Mark Samuel, CEO & Founder, IMPAQ Accountability Business Consultants Inc., to Present at 14th ICF Annual International Conference 2Health News:American Red Cross Wins Court Injunction Against Striking Teamsters 2...an., June 5 Fort Dodge Animal Health, a,division ...oduction of,ProHeart(R) 6, a unique heartworm prev...uncement follows a review by the U.S. Food and Dru...on,to return this life-saving product to the marke...
...Spot for the World,s Longest Indoor Stair Climb Be...on, CHICAGO, June 5 Registration for Go Vertical...o the top of the Sears,Tower, opens at 9 a.m. CDT ... is limited to the first 2,250 registrants, and wi...
... it possible to restore function to a paralyzed li...s disease? These are two of the several topics th...erence, June 16-18, hosted by Case Western Reserve...lready provided substantive benefits to many indiv...
... Three-Year Plan -, SAN ANTONIO, June 5 American...American Heartworm Society president, Dr.,Sheldon ... conduct the most,comprehensive heartworm incidenc...e through corporate sponsorship, will be,distribut...
...ely to smoke, abuse drugs, alcohol, study finds , ...ns with bipolar disorder are at greater risk of s...eneral Hospital (MGH) study that supports previous...uvenile delinquency," study leader Dr. Timothy Wil...
...cs effects of caloric restriction to extend life s...ay News) -- Resveratrol, a compound found in grape... may protect the heart and slow the effects of agi... percent fewer calories than a typical diet that h...
Other Medicine News:Health News:Fort Dodge Animal Health Announces Reintroduction of ProHeart 6 to the U.S. Veterinary Market 2Health News:Fort Dodge Animal Health Announces Reintroduction of ProHeart 6 to the U.S. Veterinary Market 3Health News:Fort Dodge Animal Health Announces Reintroduction of ProHeart 6 to the U.S. Veterinary Market 4Health News:Fort Dodge Animal Health Announces Reintroduction of ProHeart 6 to the U.S. Veterinary Market 5Health News:Go Vertical Chicago 2008 Sears Tower Stair Climb Registration Opens June 10 2Health News:Go Vertical Chicago 2008 Sears Tower Stair Climb Registration Opens June 10 3Health News:Premier conference on neurotechnology and deep brain stimulation to be held in Cleveland June 16-18 2Health News:American Heartworm Society Announces Heartworm Incidence Survey 2Health News:Bipolar Teens at Greater Risk of Substance Abuse 2Health News:Red Wine Compound Helps Heart, May Slow Aging 2(Date:12/3/2009)...., Dec. 3 Ted Karkus, Ch...: QGLY ) www.quigleyco.com announced today that...pportunities to develop prescription pharmaceutica... its best interests to focus primarily on the OTC/...re not limited to its Cold-EEZE® and Kids-EEZ...
(Date:12/3/2009)..., Pa., Dec. 3 Radiology imaging le...ord integration capabilities at the November 2009 ...e Connect.PACS(TM) product, enabling the first r...the latest release in the company,s newly branded ...o: http://www.newscom.com/cgi-bin/prnh/20091203/...
(Date:12/3/2009)...LM, Denmark and SAN DIEGO, California, December 3 ...Inhibits miR-122, a microRNA Important for,Hepatit...cing Hepatitis C,Virus in the Bloodstream in Chimp...irus , - SPC3649 Demonstrates Efficacy Wi...Adverse Events in the Treated Animals - Signaling ...
Breaking Medicine Technology:Quigley CEO, Ted Karkus, Announces Phase One of 2010 Strategic Plan; Karkus Reports that the Primary Focus will be on Leveraging its OTC Platform; Company Aggressively Seeking Product Acquisitions and Line Extensions which Leverage its Distribution 2Quigley CEO, Ted Karkus, Announces Phase One of 2010 Strategic Plan; Karkus Reports that the Primary Focus will be on Leveraging its OTC Platform; Company Aggressively Seeking Product Acquisitions and Line Extensions which Leverage its Distribution 3MEDRAD Demonstrates PACS Injection-Record Integration at RSNA 2009 2MEDRAD Demonstrates PACS Injection-Record Integration at RSNA 2009 3New Data Shows Breakthrough microRNA-Targeted Therapy Developed Using Santaris Pharma A/S Proprietary LNA Technology Holds Promise as New Treatment for Hepatitis C 2New Data Shows Breakthrough microRNA-Targeted Therapy Developed Using Santaris Pharma A/S Proprietary LNA Technology Holds Promise as New Treatment for Hepatitis C 3New Data Shows Breakthrough microRNA-Targeted Therapy Developed Using Santaris Pharma A/S Proprietary LNA Technology Holds Promise as New Treatment for Hepatitis C 4New Data Shows Breakthrough microRNA-Targeted Therapy Developed Using Santaris Pharma A/S Proprietary LNA Technology Holds Promise as New Treatment for Hepatitis C 5Retail Union Head Blasts Merchants Group for Opposition to Health Care Reform 50125 1Veterans Affairs Researchers Study Benefits of Robot for Ankle Rehabilitation 50124 1Veterans Affairs Researchers Study Benefits of Robot for Ankle Rehabilitation 50124 2Veterans Affairs Researchers Study Benefits of Robot for Ankle Rehabilitation 50124 3Veterans Affairs Researchers Study Benefits of Robot for Ankle Rehabilitation 50124 4Cancer Researchers Link DICER1 Gene Mutation to Rare Childhood Cancer 50122 1Cancer Researchers Link DICER1 Gene Mutation to Rare Childhood Cancer 50122 2Cancer Researchers Link DICER1 Gene Mutation to Rare Childhood Cancer 50122 3...ergy, activity and patient tolerance observed in G...ROS(R) continuous,delivery therapy, WASHINGTON, Ma...Inc., a privately held biopharmaceutical company, ...from a Phase 2 study comparing,the combination of ... interferon alone in treatment-naive patients with...
...--(BUSINESS WIRE)--May 21, 2007 - Results from a n...isease Week (DDW),conference, showed that more tha...virus (HCV) infection who were treated,successfull...etectable virus up to seven years later - validati...atients, according to study,authors. Currently, th...
Other Medicine Technology:Intarcia Therapeutics Announces Presentation of Final Results From,a Phase 2 Combination Study for the Treatment of Hepatitis C at the,Digestive Disease Week Conference 2Intarcia Therapeutics Announces Presentation of Final Results From,a Phase 2 Combination Study for the Treatment of Hepatitis C at the,Digestive Disease Week Conference 3Intarcia Therapeutics Announces Presentation of Final Results From,a Phase 2 Combination Study for the Treatment of Hepatitis C at the,Digestive Disease Week Conference 4Pegasys Study Authors Conclude that Patients Successfully Treated,for Hepatitis C Can be Considered ''Cured'' 2Pegasys Study Authors Conclude that Patients Successfully Treated,for Hepatitis C Can be Considered ''Cured'' 3Pegasys Study Authors Conclude that Patients Successfully Treated,for Hepatitis C Can be Considered ''Cured'' 4Pegasys Study Authors Conclude that Patients Successfully Treated,for Hepatitis C Can be Considered ''Cured'' 5Pegasys Study Authors Conclude that Patients Successfully Treated,for Hepatitis C Can be Considered ''Cured'' 6...ghly effective surgical alternative for the treatm...s positioned close to the high pressure zone of th...ree support of the urethra in the correct position...es, with minimal tissue dissection. Clinical studi...
...s, the PeaceKeeper 20 gauge multi-modality intraoc...Field comprehensive family of lightweight Eraser b... Combining highly effective bipolar hemostasis wit... in a single use, sterile instrument, the PeaceKee...
SUR-FIT® AutoLock® Urostomy Pouch with Accuseal® Tap
SUR-FIT Natura® Urostomy Pouch
Medicine Products: